In order to use inno-swiss.com you must enable Javascript. How to enable Javascript
— With a new generation of sweet vaccines based on sugar, Malcisbo gets at animals’ bacteria and worms. Thanks to their innovative technology, the startup receives CHF 130'000 from venture kick. The first targets of ...
— Lieu: BioArk à Monthey Date: Jeudi 10 juin 2010 à 13h45 Descriptif La Fondation The Ark et le BioArk de Monthey ont le plaisir de vous inviter à cette journée dédiée au domaine des sciences ...
— More than 130 young entrepreneurs applied for one of the most important awards for young Swiss ventures. After the analysis by a renowned judging panel, nine finalists are still in the race to win the ...
— Medipol, a biotech company based at the EPFL Science Park in Lausanne, Switzerland, will be heading a consortium of four European partners to develop a next generation vaccine against the influenza virus. The four year ...
— Nicolas Durand is on his way to the success. He just won the "Prix du jeune entrepreneur" 2010 supported by the French Advisory Committee for Foreign Trade in Switerzland. Nicolas Durand has been granted CHF ...
— Nanodimension, headed by Aymeric Sallin, an EPFL alum and great friend of swissnex, invested in a second round of financing into Selecta Biosciences, a spinoff of Bob Langer. See article attached for more info! The ...
— The Swiss biotech startup ProteoMediX wins 130‘000 CHF at the latest venture kick round. ProteoMediX evolved from a research collaboration of ETHZ with hospitals in Zurich and St. Gallen. The spin-off developed a new ...
— As the Swiss Cancer League marks its centenary, its president tells swissinfo.ch that the expected rise in cancer cases will present never seen before challenges.
Here you can report bugs/abuse or make suggestions.Please be as precise as you can.Thanks for helping us make inno-swiss.com better!
Send or Cancel
